Are Access Costs and Income Associated With Treatment Decision‐Making and Clinical Outcomes in Rural Patients Presenting With Upper Gastrointestinal Malignancy?
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.28140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Simon S Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Loyola University Medical Center, Maywood, Illinois, USA. Hauptthemen laut MEDLINE: Income, Gastrointestinal Neoplasms, Rural Population, Health Services Accessibility. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background and Objective(s) Few studies evaluate the price elasticity of demand or the relationships between costs of access, patient income, treatment decision making and outcome in rural patients with upper gastrointestinal malignancy.
Methods
We queried the National Cancer Database to identify rural patients presenting with clinical stages I–III esophagus, stomach, pancreas, hepatocellular (HCC) and cholangiocarcinoma between 2004 and 2020. Access cost was defined as (distance to treating center) × (regional gas price)/(regional vehicle fuel efficiency). Patients within the highest (HAC) and lowest (LAC) cost quintiles were selected for analysis. These were subcategorized based on income quartile: High income/High Access Cost (HI/HAC), High Income/Low Access Cost (HI/LAC), Low Income/High Access Cost (LI/HAC), Low Income/Low Access Cost (LI/LAC).
Results
A total of 9582 patients met inclusion criteria. Median access cost was $26.61 (IQR: [$10.57–$73.70]). Patients in the HI/HAC cohort were more likely to undergo treatment at academic centers (79.5%, HI/HAC, 49.6%, HI/LAC, 78.5%, LI/HAC, 38.0%, LI/LAC), undergo neoadjuvant chemotherapy (23.8%, 12.6%, 17.7%, 10.4%) undergo surgery (46.6%, 29.6%, 39.7%, 20.8%), undergo liver transplantation for HCC (30.2%, 5.86%, 18.1%, 2.04%) and demonstrated higher rates of 5‐year overall survival (42.4%, 25.6%, 32.2%, 19.0%) than those with HI/LAC, LI/HAC, and LI/LAC cohorts (all p < 0.01).
Conclusions
Among rural patients undergoing treatment for upper gastrointestinal malignancy elasticity of demand for service varies. Patients willing and able to pay for travel are more likely to receive neoadjuvant chemotherapy, undergo resection and demonstrate improved overall survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Loyola University Medical Center, Maywood, Illinois, USA.
- Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
- Department of Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, Illinois, USA.
- Department of Surgery, Edward Hines Jr. Veterans Administration Hospital, Hines, Illinois, USA.
- Department of Surgery, University of Utah, Salt Lake City, Utah, USA.
- Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Simon S Park
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Park, S. S., Verm, R. A., Abdelsattar, Z. M., Luchette, F. A., Baker, T. B., & Baker, M. S. (2025). Are Access Costs and Income Associated With Treatment Decision‐Making and Clinical Outcomes in Rural Patients Presenting With Upper Gastrointestinal Malignancy?. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28140
Vancouver
Park SS, Verm RA, Abdelsattar ZM, Luchette FA, Baker TB, Baker MS. Are Access Costs and Income Associated With Treatment Decision‐Making and Clinical Outcomes in Rural Patients Presenting With Upper Gastrointestinal Malignancy?. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28140
BibTeX
@article{Park2025,
author = {Park, Simon S and Verm, Raymond A and Abdelsattar, Zaid M and Luchette, Fred A and Baker, Talia B and Baker, Marshall S},
title = {Are Access Costs and Income Associated With Treatment Decision‐Making and Clinical Outcomes in Rural Patients Presenting With Upper Gastrointestinal Malignancy?},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.28140}
}
EUVIMED